Biohaven Pharmaceuticals completes venture financing

On March 7, neurology company Biohaven Pharmaceutical Holding Co. Ltd. (New Haven, Conn.) raised $40 million in the second tranche of a series A round led by Venrock, bringing the total raised to $80...